The FDA has authorized the use of Pfizer-BioNTech's vaccine for children 12 years and older. FDA’s authorization was based on data showing the vaccine is safe and effective in this age group. Pfizer-BioNTech's vaccine has been through extremely tough safety tests, which includes continuing scientific studies in children and teenagers.
Clinical data showed Pfizer-BioNTech was 100 percent effective in preventing Covid-19 for children ages 12 to 15. For those 16 and above, the vaccine was found to be 95 percent effective. Side effects -- such as vaccination site soreness, tiredness, and fever -- were generally minimal in both age groups.
Pfizer-BioNTech is expected to seek FDA authorization for children aged 2 to 11 years in September. Moderna and Johnson & Johnson are also carrying out clinical trials for infant to teenage use of their Covid-19 vaccines, which are currently only available to those 18 years of age and older.
While symptoms from Covid-19 haven't been as bad in children, they can still be infected, get sick, and spread the virus. The Centers for Disease Control and Prevention (CDC) recommends that all eligible children -- right now, that's everyone 12 years and above -- get the shot to protect themselves and others.
To learn more about how vaccines are reviewed for safety and effectiveness click here.
For an interactive map directing you to vaccine availability for children in your area visit here.